Singapore markets closed

Cibus, Inc. (CBUS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.84+0.30 (+1.93%)
At close: 04:00PM EDT
16.14 +0.30 (+1.89%)
After hours: 05:23PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close15.54
Open15.62
Bid15.53 x 100
Ask19.98 x 200
Day's range15.50 - 16.03
52-week range8.90 - 38.85
Volume34,855
Avg. volume64,582
Market cap392.282M
Beta (5Y monthly)1.95
PE ratio (TTM)N/A
EPS (TTM)-25.95
Earnings date09 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est23.00
  • GlobeNewswire

    Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call

    SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report first quarter 2024 financial results on Thursday, May 9, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updat

  • Simply Wall St.

    Cibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

    Cibus ( NASDAQ:CBUS ) Full Year 2023 Results Key Financial Results Net loss: US$267.6m (loss widened by US$250.7m from...

  • GlobeNewswire

    Cibus Reports Fourth Quarter Financial Results and Provides Business Update

    Completed successful transfers of gene edited elite germplasm back to customers for commercialization for each of its three developed productivity traits: Pod Shatter Reduction (PSR) in Canola and Herbicide Tolerance (HT1 and HT3) in Rice Signed collaboration agreements for trait development with multiple major seed companies, including Bayer, Loveland Products (subsidiary of Nutrien Ltd), Nuseed, and Interoc Reported achievement of successful greenhouse results for two different modes of action